Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Fetal Tissue, Stem Cells & Bioethics

134 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
134 results
featured-image
Fetal Tissue, Stem Cells & Bioethics

Lozier Institute on Gene-Editing: Focus on Helping Patients, Not Creating Designer Babies

“Use of CRISPR to manipulate genes or remove them entirely from the human germline presents a host of scientific and ethical questions that we can’t possibly answer at this time,” said Dr. David Prentice, CLI’s vice president and research director, “Nowhere is this more evident than how researchers describe the ‘theoretical’ benefits of germline editing, but theoretical is all this is. We simply don’t have any ability to ascertain the long-term effects germline mutation will have on future generations who inherit a mutated gene or the lack of a gene. Our focus should be on helping patients, not on designer babies."

charlotte-lozier-institute Charlotte Lozier Institute
August 28, 2019
ClosePlease login
featured-image
Fetal Tissue, Stem Cells & Bioethics

Major Pro-life Victory: HHS Cancels Huge Contract for Taxpayer-Funded Experimentation with Body Parts of Aborted Babies, Announces New Approach

Today’s move demonstrates NIH’s investment in scientifically-proven methods for research: adult stem cells, iPS cells, organoids, humanized mice constructed using postnatally sourced cells and improved non-human cell lines—just to name a few.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Use of Aborted Fetal Tissue: Questions & Answers  

On May 23, Susan B. Anthony List and Charlotte Lozier Institute hosted a hearing for Capitol Hill staff on the state of fetal issue research. The panel consisted of Drs. David Prentice, Tara Sander Lee, and James Sherley, and was moderated by SBA List's Autumn Christensen. These are their questions and answers, as provided to staff.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Adult Stem Cells: Successful Standard for Regenerative Medicine

Adult stem cells are the successful standard for stem cells. Although in the past their regenerative/reparative capacity was ignored, misunderstood, or even maligned, a rapidly growing host of clinical applications are being developed, and the clinical utility of adult stem cells is increasingly validated in the literature.

featured-image
Fetal Tissue, Stem Cells & Bioethics

CLI Scientists Respond to Letter on Genetically Modified Children: Not Enough

Yesterday 18 scientists representing seven countries published a letter calling for a “global moratorium on all clinical uses of human germline editing — that is, changing heritable DNA (in sperm, eggs or embryos) to make genetically modified children.” Charlotte Lozier Institute (CLI), the research and education arm of Susan B. Anthony List, released the following statement in response...

featured-image
Fetal Tissue, Stem Cells & Bioethics

Written Testimony of David A. Prentice, Ph.D., in Support of Ethical Alternatives to Aborted Fetal Tissue Research

On Thursday, December 13, 2018, the U.S. House of Representatives subcommittee on Healthcare, Benefits, and Administrative Rules and Government Operations for the Committee on Oversight and Government Reform held a hearing on “Exploring Alternatives to Fetal Tissue Research.” 

featured-image
Fetal Tissue, Stem Cells & Bioethics

Written Testimony of Tara Sander Lee, Ph.D., in Support of Ethical Alternatives to Aborted Fetal Tissue Research

On Thursday, December 13, 2018, the U.S. House of Representatives subcommittee on Healthcare, Benefits, and Administrative Rules and Government Operations for the Committee on Oversight and Government Reform held a hearing on "Exploring Alternatives to Fetal Tissue Research." The hearing was called as the U.S. Department of Health and Human Services re-evaluates funding for research using tissue from aborted babies. Charlotte Lozier Institute Associate Scholar Tara Sander Lee, Ph.D., submitted the following written testimony in support of using ethical alternatives to aborted fetal tissue research.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Congress to Hear from Scientific Experts on Ethical Alternatives to Aborted Fetal Tissue Research

A U.S. House of Representatives subcommittee will hold a hearing on “Exploring Alternatives to Fetal Tissue Research” tomorrow, December 13 at 10:00 AM in Rayburn HOB 2154. The hearing comes as the U.S. Department of Health and Human Services re-evaluates funding for research using tissue from aborted babies.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image